As of 4:00pm ET
| -1.40 / -1.41%|
The 3 analysts offering 12-month price forecasts for Magellan Health Inc have a median target of 105.00, with a high estimate of 108.00 and a low estimate of 100.00. The median estimate represents a +6.92% increase from the last price of 98.20.
The current consensus among 3 polled investment analysts is to Buy stock in Magellan Health Inc. This rating has held steady since June, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.